Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
SGQ 0.300 +0.0% AMCO 0.250 +0.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.400 +0.0% LIB 0.910 +0.0% SMY 0.235 +0.0% SAG 1.02 +0.0% NTH 0.165 +0.0% PEMC 0.045 +0.0% NAR 0.180 +0.0% ARG 6.99 +0.0% VMXX 0.970 +0.0% ABRA 14.01 +0.0% LAF 1.63 +0.0% AMX 4.14 +0.0% SGQ 0.300 +0.0% AMCO 0.250 +0.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.400 +0.0% LIB 0.910 +0.0% SMY 0.235 +0.0% SAG 1.02 +0.0% NTH 0.165 +0.0% PEMC 0.045 +0.0% NAR 0.180 +0.0% ARG 6.99 +0.0% VMXX 0.970 +0.0% ABRA 14.01 +0.0% LAF 1.63 +0.0% AMX 4.14 +0.0%
Financings

Trulieve completes redemption of $368M (U.S.) of notes

By The Northwire Desk — AI Analysis Dec 08, 2025 · 18:45 TRUL · 8.02 Trulieve Cannabis Corp
TRUL · Price

Executive Summary

  • Trulieve Cannabis Corp. has completed the redemption of its entire outstanding balance of 8.0% Senior Secured Notes due 2026.
  • The total cash outlay for the redemption was approximately $373 million (U.S.), covering the principal amount plus accrued and unpaid interest.
  • The notes ceased trading and were delisted from the Canadian Securities Exchange effective December 5, 2025.

Key Details

  • Instrument Redeemed: 8.0% Senior Secured Notes due 2026.
  • Principal Amount: US$368 million.
  • Total Cash Used: Approximately US$373 million (includes aggregate principal plus accrued and unpaid interest to, but excluding, the redemption date).
  • Redemption Date: December 5, 2025.
  • Trading Status: Notes ceased trading on the Canadian Securities Exchange under symbol TRUL.NT.U as of the close of trading on Dec. 5, 2025.
  • Listing Status: Notes were delisted as of Dec. 5, 2025.
  • Trustee/Agent: Additional information available from Odyssey Trust Company.
Read the original news release →

More from Trulieve Cannabis Corp

Jul 01, 2026 · 08:10

Georgia expansion marks first sales, but revenue compression and margin pressure remain key headwinds.

Production / Operations Jun 09, 2026 · 08:00

Trulieve's $50M Buyback Signals Confidence, But 43% Run-Up Into the Print Caps Near-Term Upside

Other Jun 05, 2026 · 07:00

Trulieve’s NYSE Debut Cements First-Mover Advantage in Post‑Rescheduling U.S. Medical Cannabis, With Texas and Georgia Upside in Focus

Regulatory May 21, 2026 · 08:45

Trulieve Stabilizes Post-Rescheduling Rally as Domestication Vote Looms

Production / Operations May 13, 2026 · 16:30

Trulieve swaps Canadian roots for Delaware law, but the home-run catalyst still awaits a rulemaking hearing.

Other May 07, 2026 · 06:15

Trulieve Posts Profit as Cannabis Rescheduling Lifts Margins

Earnings